$MTNB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Matinas BioPharma Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Matinas BioPharma Holdings, Inc.. Get notifications about new insider transactions in Matinas BioPharma Holdings, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Option Exercise | C | 0.50 | 15 | 8 | 0 | |
Jun 24 2021 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | C | 0.00 | 30,000 | 0 | 840,011 | 810 K to 840 K (+3.70 %) |
Jun 24 2021 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | J | 0.00 | 6,000 | 0 | 810,011 | 804 K to 810 K (+0.75 %) |
Jun 24 2021 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Option Exercise | C | 0.50 | 6 | 3 | 0 | |
Jun 24 2021 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Buy | C | 0.00 | 12,000 | 0 | 266,263 | 254.3 K to 266.3 K (+4.72 %) |
Jun 24 2021 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Buy | J | 0.00 | 2,400 | 0 | 254,263 | 251.9 K to 254.3 K (+0.95 %) |
May 24 2021 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | G | 0.50 | 100 | 50 | 100 | |
May 24 2021 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | G | 0.50 | 100 | 50 | 0 | |
May 24 2021 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 1,145,905 | 0 | 1,320,905 | 175 K to 1.3 M (+654.80 %) |
May 24 2021 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 1,145,905 | 0 | 0 | 1.1 M to 0 (-100.00 %) |
May 24 2021 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 50,000 | 0 | 175,000 | 125 K to 175 K (+40.00 %) |
May 24 2021 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 50,000 | 0 | 494,622 | 544.6 K to 494.6 K (-9.18 %) |
Apr 05 2021 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 7,560 | 0 | 251,863 | 244.3 K to 251.9 K (+3.09 %) |
Jan 04 2021 | MTNB | Matinas BioPharma ... | Matkovits Theresa | Chief Development O ... | Option Exercise | A | 1.36 | 425,000 | 578,000 | 425,000 | |
Jan 04 2021 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Option Exercise | A | 1.36 | 200,000 | 272,000 | 200,000 | |
Jan 04 2021 | MTNB | Matinas BioPharma ... | Hui Liu | Chief Technology Of ... | Option Exercise | A | 1.36 | 250,000 | 340,000 | 250,000 | |
Jan 04 2021 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Option Exercise | A | 1.36 | 1,600,000 | 2,176,000 | 1,600,000 | |
Jan 04 2021 | MTNB | Matinas BioPharma ... | Kucinski Keith A | Chief Financial Off ... | Option Exercise | A | 1.36 | 500,000 | 680,000 | 500,000 | |
Jan 04 2021 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 11,673 | 0 | 244,303 | 232.6 K to 244.3 K (+5.02 %) |
Jan 04 2021 | MTNB | Matinas BioPharma ... | Ferguson James J. III | Chief Medical Offic ... | Option Exercise | A | 1.36 | 575,000 | 782,000 | 575,000 | |
Dec 03 2020 | MTNB | Matinas BioPharma ... | Hui Liu | Chief Technology Of ... | Option Exercise | A | 1.07 | 350,000 | 374,500 | 350,000 | |
Nov 10 2020 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Option Exercise | A | 0.82 | 122,605 | 100,536 | 122,605 | |
Nov 10 2020 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.82 | 122,605 | 100,536 | 122,605 | |
Nov 10 2020 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 0.82 | 122,605 | 100,536 | 122,605 | |
Oct 06 2020 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 20,725 | 0 | 232,630 | 211.9 K to 232.6 K (+9.78 %) |
Aug 24 2020 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.83 | 20,000 | 16,600 | 3,301,983 | 3.3 M to 3.3 M (+0.61 %) |
Jul 02 2020 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 20,537 | 0 | 211,905 | 191.4 K to 211.9 K (+10.73 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Buy | J | 0.00 | 30,000 | 0 | 544,622 | 514.6 K to 544.6 K (+5.83 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | J | 0.00 | 4,500 | 0 | 804,011 | 799.5 K to 804 K (+0.56 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Buy | J | 0.00 | 1,800 | 0 | 191,368 | 189.6 K to 191.4 K (+0.95 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | J | 0.00 | 3,600 | 0 | 115,292 | 111.7 K to 115.3 K (+3.22 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Buy | J | 0.00 | 3,000 | 0 | 1,429,565 | 1.4 M to 1.4 M (+0.21 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | J | 0.00 | 3,600 | 0 | 621,158 | 617.6 K to 621.2 K (+0.58 %) |
Jun 24 2020 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | J | 0.00 | 25,500 | 0 | 3,281,983 | 3.3 M to 3.3 M (+0.78 %) |
Jun 19 2020 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Option Exercise | A | 0.82 | 500,000 | 407,500 | 500,000 | |
Jun 19 2020 | MTNB | Matinas BioPharma ... | Matkovits Theresa | Chief Development O ... | Option Exercise | A | 0.82 | 175,000 | 142,625 | 175,000 | |
Jun 19 2020 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Option Exercise | A | 0.82 | 50,000 | 40,750 | 50,000 | |
Jun 19 2020 | MTNB | Matinas BioPharma ... | Kucinski Keith A | Chief Financial Off ... | Option Exercise | A | 0.82 | 175,000 | 142,625 | 175,000 | |
Jun 19 2020 | MTNB | Matinas BioPharma ... | Ferguson James J. III | Chief Medical Offic ... | Option Exercise | A | 0.82 | 250,000 | 203,750 | 250,000 | |
Jun 05 2020 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 2,639,039 | 0 | 2,639,039 | 0 to 2.6 M |
Jun 05 2020 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 2,639,039 | 0 | 125,000 | 2.8 M to 125 K (-95.48 %) |
May 18 2020 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Buy | P | 0.73 | 100,000 | 73,050 | 400,000 | 300 K to 400 K (+33.33 %) |
May 15 2020 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 2,639,039 | 0 | 2,764,039 | 125 K to 2.8 M (+2,111.23 %) |
May 15 2020 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 2,639,039 | 0 | 1,145,905 | 3.8 M to 1.1 M (-69.72 %) |
Apr 08 2020 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Option Exercise | M | 0.50 | 952,676 | 476,338 | 0 | |
Apr 08 2020 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | M | 0.50 | 278,407 | 139,204 | 1,337,399 | 1.1 M to 1.3 M (+26.29 %) |
Mar 18 2020 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.65 | 10,000 | 6,500 | 10,000 | 0 to 10 K |
Mar 18 2020 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | P | 0.65 | 10,000 | 6,500 | 799,511 | 789.5 K to 799.5 K (+1.27 %) |
Mar 18 2020 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.65 | 10,000 | 6,500 | 10,000 | 0 to 10 K |
Mar 18 2020 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | P | 0.65 | 10,000 | 6,500 | 799,511 | 789.5 K to 799.5 K (+1.27 %) |
Nov 26 2019 | MTNB | Matinas BioPharma ... | Kucinski Keith A | Chief Financial Off ... | Buy | P | 1.23 | 58,000 | 71,160 | 94,500 | 36.5 K to 94.5 K (+158.90 %) |
Nov 26 2019 | MTNB | Matinas BioPharma ... | Kucinski Keith A | Chief Financial Off ... | Buy | P | 1.20 | 36,500 | 43,807 | 36,500 | 0 to 36.5 K |
Nov 19 2019 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Buy | P | 1.06 | 100,000 | 105,530 | 300,000 | 200 K to 300 K (+50.00 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | C | 0.00 | 20,000 | 0 | 0 | |
Oct 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | P | 0.00 | 20,000 | 0 | 20,000 | |
Oct 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 38,066 | 0 | 504,049 | 466 K to 504 K (+8.17 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Buy | J | 0.00 | 20,000 | 0 | 465,983 | 446 K to 466 K (+4.48 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Buy | J | 0.00 | 48,000 | 0 | 445,983 | 398 K to 446 K (+12.06 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Buy | C | 0.00 | 200,000 | 0 | 397,983 | 198 K to 398 K (+101.02 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Buy | J | 0.00 | 1,200 | 0 | 156,124 | 154.9 K to 156.1 K (+0.77 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 25,179 | 0 | 154,924 | 129.7 K to 154.9 K (+19.41 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Option Exercise | C | 0.00 | 20,000 | 0 | 0 | |
Oct 02 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Option Exercise | P | 0.00 | 20,000 | 0 | 20,000 | |
Oct 02 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | J | 0.00 | 17,000 | 0 | 3,256,483 | 3.2 M to 3.3 M (+0.52 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | W | 0.00 | 6,600 | 0 | 1,058,992 | 1.1 M to 1.1 M (+0.63 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | J | 0.00 | 48,000 | 0 | 1,052,392 | 1 M to 1.1 M (+4.78 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | C | 0.00 | 200,000 | 0 | 993,992 | 794 K to 994 K (+25.19 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | J | 0.00 | 2,400 | 0 | 609,298 | 606.9 K to 609.3 K (+0.40 %) |
Oct 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 29,739 | 0 | 606,898 | 577.2 K to 606.9 K (+5.15 %) |
Aug 22 2019 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | P | 0.66 | 20,000 | 13,200 | 109,292 | 89.3 K to 109.3 K (+22.40 %) |
Aug 21 2019 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | P | 0.68 | 14,650 | 9,975 | 786,511 | 771.9 K to 786.5 K (+1.90 %) |
Aug 21 2019 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | P | 0.68 | 14,650 | 9,975 | 786,511 | 771.9 K to 786.5 K (+1.90 %) |
Aug 21 2019 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | P | 0.68 | 20,000 | 13,650 | 89,292 | 69.3 K to 89.3 K (+28.86 %) |
Aug 21 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.70 | 10,400 | 7,268 | 804,392 | 794 K to 804.4 K (+1.31 %) |
Aug 21 2019 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Buy | P | 0.68 | 20,000 | 13,650 | 89,292 | 69.3 K to 89.3 K (+28.86 %) |
Aug 21 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.70 | 10,400 | 7,268 | 804,392 | 794 K to 804.4 K (+1.31 %) |
Aug 20 2019 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Buy | P | 0.72 | 100,000 | 71,850 | 200,000 | 100 K to 200 K (+100.00 %) |
Jul 02 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 21,879 | 0 | 577,159 | 555.3 K to 577.2 K (+3.94 %) |
Jul 02 2019 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 18,524 | 0 | 129,745 | 111.2 K to 129.7 K (+16.66 %) |
Jul 02 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 28,005 | 0 | 197,983 | 170 K to 198 K (+16.48 %) |
Jun 18 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.80 | 15,000 | 12,000 | 3,239,483 | 3.2 M to 3.2 M (+0.47 %) |
Jun 13 2019 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Buy | P | 0.80 | 12,487 | 9,980 | 771,861 | 759.4 K to 771.9 K (+1.64 %) |
Jun 13 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.80 | 20,000 | 15,998 | 3,224,483 | 3.2 M to 3.2 M (+0.62 %) |
Jun 11 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.82 | 15,000 | 12,300 | 3,204,483 | 3.2 M to 3.2 M (+0.47 %) |
Jun 10 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.89 | 20,000 | 17,800 | 3,189,483 | 3.2 M to 3.2 M (+0.63 %) |
Jun 03 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.94 | 80,000 | 75,200 | 3,169,483 | 3.1 M to 3.2 M (+2.59 %) |
May 20 2019 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 0.95 | 150,000 | 142,500 | 3,089,483 | 2.9 M to 3.1 M (+5.10 %) |
May 20 2019 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Buy | P | 0.95 | 100,000 | 95,250 | 100,000 | 0 to 100 K |
May 20 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Buy | P | 0.96 | 25,000 | 24,115 | 172,959 | 148 K to 173 K (+16.90 %) |
Apr 03 2019 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 14,565 | 0 | 111,221 | 96.7 K to 111.2 K (+15.07 %) |
Apr 03 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 22,019 | 0 | 122,019 | 100 K to 122 K (+22.02 %) |
Apr 03 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 17,202 | 0 | 555,280 | 538.1 K to 555.3 K (+3.20 %) |
Feb 27 2019 | MTNB | Matinas BioPharma ... | Ferguson James J. III | Chief Medical Offic ... | Option Exercise | A | 1.09 | 350,000 | 381,500 | 350,000 | |
Feb 13 2019 | MTNB | Matinas BioPharma ... | Kucinski Keith A | Chief Financial Off ... | Option Exercise | A | 1.08 | 275,000 | 297,000 | 275,000 | |
Feb 13 2019 | MTNB | Matinas BioPharma ... | Matkovits Theresa | Chief Development O ... | Option Exercise | A | 1.08 | 350,000 | 378,000 | 350,000 | |
Feb 13 2019 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Option Exercise | A | 1.08 | 750,000 | 810,000 | 750,000 | |
Feb 13 2019 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Option Exercise | A | 1.08 | 150,000 | 162,000 | 150,000 | |
Feb 12 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Gift | G | 0.00 | 3,932,903 | 0 | 100,000 | 4 M to 100 K (-97.52 %) |
Jan 04 2019 | MTNB | Matinas BioPharma ... | Kucinski Keith A | Chief Financial Off ... | Option Exercise | A | 0.61 | 250,000 | 152,500 | 250,000 | |
Jan 04 2019 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 40,337 | 0 | 4,032,903 | 4 M to 4 M (+1.01 %) |
Jan 04 2019 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 31,513 | 0 | 538,078 | 506.6 K to 538.1 K (+6.22 %) |
Jan 04 2019 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 26,681 | 0 | 96,656 | 70 K to 96.7 K (+38.13 %) |
Nov 05 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Nov 05 2018 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Option Exercise | A | 0.74 | 128,299 | 94,941 | 128,299 | |
Oct 16 2018 | MTNB | Matinas BioPharma ... | Matkovits Theresa | Chief Development O ... | Option Exercise | A | 0.79 | 350,000 | 276,500 | 350,000 | |
Oct 03 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 19,294 | 0 | 69,975 | 50.7 K to 70 K (+38.07 %) |
Oct 03 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Grant | A | 0.00 | 9,715 | 0 | 42,069 | 32.4 K to 42.1 K (+30.03 %) |
Oct 03 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 20,381 | 0 | 506,565 | 486.2 K to 506.6 K (+4.19 %) |
Oct 03 2018 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 26,087 | 0 | 3,992,566 | 4 M to 4 M (+0.66 %) |
Sep 06 2018 | MTNB | Matinas BioPharma ... | LEPORE PATRICK G | Director | Option Exercise | A | 0.44 | 150,000 | 66,000 | 150,000 | |
Jul 11 2018 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 55,300 | 0 | 3,966,479 | 3.9 M to 4 M (+1.41 %) |
Jul 11 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 43,203 | 0 | 486,184 | 443 K to 486.2 K (+9.75 %) |
Jul 11 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 32,259 | 0 | 50,681 | 18.4 K to 50.7 K (+175.11 %) |
Jul 11 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Grant | A | 0.00 | 20,594 | 0 | 32,354 | 11.8 K to 32.4 K (+175.12 %) |
Jun 22 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Option Exercise | P | 0.50 | 12 | 6 | 12 | |
Jun 22 2018 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Option Exercise | P | 0.50 | 10 | 5 | 10 | |
Jun 22 2018 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Option Exercise | P | 0.50 | 85 | 43 | 85 | |
Jun 22 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Option Exercise | P | 0.50 | 6 | 3 | 6 | |
Jun 22 2018 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | President and CEO | Option Exercise | P | 0.50 | 15 | 8 | 15 | |
Jun 22 2018 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Option Exercise | P | 0.50 | 100 | 50 | 100 | |
Jun 22 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | P | 0.50 | 12 | 6 | 12 | |
May 02 2018 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Option Exercise | A | 0.44 | 150,000 | 66,000 | 150,000 | |
May 02 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Option Exercise | A | 0.44 | 100,000 | 44,000 | 100,000 | |
May 02 2018 | MTNB | Matinas BioPharma ... | DiPaolo Dominick | Sr. VP-Quality & Ma ... | Option Exercise | A | 0.44 | 150,000 | 66,000 | 150,000 | |
Apr 02 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Grant | A | 0.00 | 18,422 | 0 | 18,422 | 0 to 18.4 K |
Apr 02 2018 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Grant | A | 0.00 | 24,672 | 0 | 442,981 | 418.3 K to 443 K (+5.90 %) |
Apr 02 2018 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 31,579 | 0 | 3,911,179 | 3.9 M to 3.9 M (+0.81 %) |
Apr 02 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Grant | A | 0.00 | 11,760 | 0 | 11,760 | 0 to 11.8 K |
Mar 23 2018 | MTNB | Matinas BioPharma ... | Jabbour Jerome D | Chief Executive Off ... | Option Exercise | A | 0.98 | 1,000,000 | 980,000 | 1,000,000 | |
Feb 27 2018 | MTNB | Matinas BioPharma ... | Ende Eric J | Director | Option Exercise | A | 1.48 | 250,000 | 370,000 | 250,000 | |
Jan 05 2018 | MTNB | Matinas BioPharma ... | WIKLER MATTHEW | Director | Option Exercise | A | 1.24 | 150,000 | 186,000 | 150,000 | |
Dec 29 2017 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Gift | G | 0.00 | 750,000 | 0 | 2,939,483 | 3.7 M to 2.9 M (-20.33 %) |
Dec 29 2017 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Gift | G | 0.00 | 750,000 | 0 | 1,750,000 | 1000 K to 1.8 M (+75.00 %) |
Oct 02 2017 | MTNB | Matinas BioPharma ... | DiPaolo Dominick | Senior VP of Compli ... | Option Exercise | A | 1.31 | 350,000 | 458,500 | 350,000 | |
Sep 15 2017 | MTNB | Matinas BioPharma ... | MANNINO RAPHAEL J | Chief Scientific Of ... | Buy | P | 1.41 | 5,000 | 7,050 | 1,424,565 | 1.4 M to 1.4 M (+0.35 %) |
Sep 11 2017 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 1.38 | 50,000 | 69,000 | 3,689,483 | 3.6 M to 3.7 M (+1.37 %) |
Sep 11 2017 | MTNB | Matinas BioPharma ... | STERN ADAM K | Director | Buy | P | 1.38 | 50,000 | 69,000 | 3,639,483 | 3.6 M to 3.6 M (+1.39 %) |
Sep 11 2017 | MTNB | Matinas BioPharma ... | Rongen Roelof | Chief Executive Off ... | Buy | P | 1.36 | 5,000 | 6,800 | 3,539,416 | 3.5 M to 3.5 M (+0.14 %) |
Sep 07 2017 | MTNB | Matinas BioPharma ... | FERRARI STEFANO | Director | Buy | P | 1.24 | 5,000 | 6,200 | 203,984 | 199 K to 204 K (+2.51 %) |
Sep 07 2017 | MTNB | Matinas BioPharma ... | CONRAD HERBERT J | Director | Buy | P | 1.30 | 100,000 | 130,000 | 3,879,600 | 3.8 M to 3.9 M (+2.65 %) |
Sep 07 2017 | MTNB | Matinas BioPharma ... | Scibetta James S | Director | Buy | P | 1.29 | 5,000 | 6,450 | 418,309 | 413.3 K to 418.3 K (+1.21 %) |